Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement

By sjmartinez • May 18, 2025

Oprea AD, Ostapenko LJ, Sweitzer B, Selzer A, Irizarry-Alvarado JM, Hurtado Andrade MD, Mendez CE, Kelley KD, Stewart E, Fernandez Robles CR, Chadha RM, Camilleri M, Mathur R, Umpierrez GE, Hepner DL. Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement. Br J Anaesth. 2025 May 15:S0007-0912(25)00214-4. doi: 10.1016/j.bja.2025.04.001. Epub ahead of print. PMID: 40379536.

Tags: Cedars Sinai DoM, diabetes mellitus, Endocrinology, gastric emptying, glucagon-like peptide 1 receptor agonists, major adverse cardiovascular events, Obesity, perioperative care, Publications

Glucagon-Like Peptide-1 Receptor Agonists and Incidence of Dementia Among Older Adults With Type 2 Diabetes : A Target Trial Emulation

Inoue K, Saliba D, Gotanda H, Moin T, Mangione CM, Klomhaus AM, Tsugawa Y. Glucagon-Like Peptide-1 Receptor Agonists and Incidence of Dementia Among Older Adults[...]

Detecting structural heart disease from electrocardiograms using AI

Poterucha TJ, Jing L, Ricart RP, Adjei-Mosi M, Finer J, Hartzel D, Kelsey C, Long A, Rocha D, Ruhl JA, vanMaanen D, Probst MA, Daniels[...]

Phase 2a Study of Baxdrostat in Primary Aldosteronism

Turcu AF, Freeman MW, Bancos I, Ben-Shlomo A, Hamidi O, Hamrahian AH, Huang W, Kirschner LS, Sam R, Mallappa A, Tuyishimire B, Lihn AS, Perl[...]